Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HER-2 Positive Malignant Carcinoma of Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05754502
What this trial is testing

Observational Study of Effectiveness and Safety of Trastuzumab Emtansine (T-DM1) in HER2-positive Breast Cancer Patients With Residual Invasive Disease Following Neoadjuvant Chemotherapy and Anti-HER2 Target Therapy

Who this might be right for
Breast Cancer
Consorzio Oncotech 300
Not applicableUnknownNCT04276337
What this trial is testing

Genetic Characteristics of HER2 Positive Breast Cancer With Neoadjuvant TCHP Chemotherapy

Who this might be right for
HER2-positive Breast CancerChemotherapy EffectCirculating Tumor DNA
Samsung Medical Center 50
Not applicableStudy completedNCT07416409
What this trial is testing

Effectiveness, Safety, and Tolerability of Anti-HER2 Drugs as Targeted Therapy for Egyptian Patients With ERBB2-Positive Breast Cancer

Who this might be right for
Breast NeoplasmsOncologyHER2-positive Breast Cancer+1 more
Deraya University 80
Early research (Phase 1)Study completedNCT04382352
What this trial is testing

B002 in Patients With HER2-positive Breast Cancer

Who this might be right for
Recurrent Breast CancerMetastatic Breast Cancer
Shanghai Pharmaceuticals Holding Co., Ltd 23
Testing effectiveness (Phase 2)Looking for participantsNCT07739511
What this trial is testing

Paclitaxel Oral Solution in HER2-Positive Breast Cancer Neoadjuvant Therapy: A Dose-Finding Study

Who this might be right for
HER2 + Breast Cancer
Liu Shu 30
Large-scale testing (Phase 3)Study completedNCT02187744
What this trial is testing

PF-05280014 Or Trastuzumab Plus Taxotere® And Carboplatin In HER2 Positive Breast Cancer In The Neoadjuvant Setting (REFLECTIONS B327-04)

Who this might be right for
Early Breast Cancer
Pfizer 226
Testing effectiveness (Phase 2)Active Not RecruitingNCT05710328
What this trial is testing

Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial

Who this might be right for
Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8HER2-Positive Breast Carcinoma+1 more
ECOG-ACRIN Cancer Research Group 235
Not applicableLooking for participantsNCT06557057
What this trial is testing

Impact of Aromatase Inhibitor Therapy on Glucose Homeostasis and Diabetes Risk

Who this might be right for
HER2-Positive Breast Carcinoma
Mayo Clinic 81
Testing effectiveness (Phase 2)Active Not RecruitingNCT05710666
What this trial is testing

Neoadjuvant Trastuzumab Deruxtecan (T-DXd) With Response-directed Definitive Therapy in Early Stage HER2-positive Breast Cancer (SHAMROCK Study)

Who this might be right for
HER2-positive Breast Cancer
Cancer Trials Ireland 11
Testing effectiveness (Phase 2)Study completedNCT04307329
What this trial is testing

Monalizumab and Trastuzumab In Metastatic HER2-pOSitive breAst Cancer: MIMOSA-trial

Who this might be right for
Breast Cancer
The Netherlands Cancer Institute 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07581795
What this trial is testing

Study of Paclitaxel Polymeric Micelles Combined With HP and Adebelimab Versus Taxane Combined With HP as First-Line Treatment for Advanced HER2-Positive Breast Cancer

Who this might be right for
Advanced HER2-positive Breast Cancer
Fudan University 140
Not applicableLooking for participantsNCT06723990
What this trial is testing

Evaluation of HER2DX Assay on Treatment Decisions in Patients With Early Stage HER2+ Breast Cancer: the HER2BREASTDX

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
European Institute of Oncology 60
Not applicableStudy completedNCT06907082
What this trial is testing

Study to Evaluate the Efficacy and Safety of Neoadjuvant Treatment Based on Dual Blockade With Pertuzumab and the Trastuzumab Biosimilar CT-P6 (Herzuma®) in Early HER2-positive Breast Cancer in Routine Clinical Practice

Who this might be right for
Breast Cancer
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia 106
Testing effectiveness (Phase 2)Ended earlyNCT04172597
What this trial is testing

Poziotinib in Patients With Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Activating Mutations in Advanced Malignancies

Who this might be right for
Breast CancerColorectal CancerSolid Tumor+1 more
Spectrum Pharmaceuticals, Inc 1
Testing effectiveness (Phase 2)UnknownNCT04088110
What this trial is testing

Pyrotinib Combined With Trastuzumab Plus Aromatase Inhibitor in Treatment of Breast Cancer

Who this might be right for
Breast Cancer FemaleHER2-positive Breast CancerHormone Receptor Positive Malignant Neoplasm of Breast+3 more
Fuzhou General Hospital 77
Large-scale testing (Phase 3)Study completedNCT03989037
What this trial is testing

SIBP-01 Or CN-Trastuzumab Plus Docetaxel And Carboplatin In HER2 Positive Breast Cancer

Who this might be right for
HER2-positive Early Breast Cancer
Shanghai Institute Of Biological Products 580
Early research (Phase 1)Study completedNCT02060253
What this trial is testing

Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer

Who this might be right for
HER2-positive Breast CancerMale Breast CancerRecurrent Breast Cancer+4 more
Memorial Sloan Kettering Cancer Center 9
Testing effectiveness (Phase 2)Study completedNCT00826267
What this trial is testing

6 Weeks Treatment of Locally Advanced Breast Cancer With BIBW 2992 (Afatinib) or Lapatinib or Trastuzumab

Who this might be right for
Breast Neoplasms
Boehringer Ingelheim 29
Testing effectiveness (Phase 2)UnknownNCT04639271
What this trial is testing

Pyrotinib, Trastuzumab And Abraxane in HER2-positive MBC With Brain Metastasis

Who this might be right for
Breast CancerHER2-positive Breast Cancer
Shandong Cancer Hospital and Institute 100
Early research (Phase 1)Study completedNCT02152943
What this trial is testing

Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients

Who this might be right for
Advanced Malignant Solid NeoplasmEstrogen Receptor PositiveHER2/Neu Positive+10 more
M.D. Anderson Cancer Center 37
Next Page